계명대학교 의학도서관 Repository

Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI

Metadata Downloads
Author(s)
Bon-Kwon KooXinyang HuJeehoon KangJinlong ZhangJun JiangJoo-Yong HahnChang-Wook NamJoon-Hyung DohBong-Ki LeeWeon KimJinyu HuangFan JiangHao ZhouPeng ChenLijiang TangWenbing JiangXiaomin ChenWenming HeSung-Gyun AhnMyeong-Ho YoonUng KimJoo-Myung LeeDoyeon HwangYou-Jeong KiEun-Seok ShinHyo-Soo KimSeung-Jea TahkJian'an Wang
Keimyung Author(s)
Nam, Chang Wook
Department
Dept. of Internal Medicine (내과학)
Journal Title
N Engl J Med
Issued Date
2022
Volume
387
Issue
9
Abstract
Background:
In patients with coronary artery disease who are being evaluated for percutaneous coronary intervention (PCI), procedures can be guided by fractional flow reserve (FFR) or intravascular ultrasonography (IVUS) for decision making regarding revascularization and stent implantation. However, the differences in clinical outcomes when only one method is used for both purposes are unclear.

Methods:
We randomly assigned 1682 patients who were being evaluated for PCI for the treatment of intermediate stenosis (40 to 70% occlusion by visual estimation on coronary angiography) in a 1:1 ratio to undergo either an FFR-guided or IVUS-guided procedure. FFR or IVUS was to be used to determine whether to perform PCI and to assess PCI success. In the FFR group, PCI was to be performed if the FFR was 0.80 or less. In the IVUS group, the criteria for PCI were a minimal lumen area measuring either 3 mm2 or less or measuring 3 to 4 mm2 with a plaque burden of more than 70%. The primary outcome was a composite of death, myocardial infarction, or revascularization at 24 months after randomization. We tested the noninferiority of the FFR group as compared with the IVUS group (noninferiority margin, 2.5 percentage points).

Results:
The frequency of PCI was 44.4% among patients in the FFR group and 65.3% among those in the IVUS group. At 24 months, a primary-outcome event had occurred in 8.1% of the patients in the FFR group and in 8.5% of those in the IVUS group (absolute difference, -0.4 percentage points; upper boundary of the one-sided 97.5% confidence interval, 2.2 percentage points; P = 0.01 for noninferiority). Patient-reported outcomes as reported on the Seattle Angina Questionnaire were similar in the two groups.

Conclusions:
In patients with intermediate stenosis who were being evaluated for PCI, FFR guidance was noninferior to IVUS guidance with respect to the composite primary outcome of death, myocardial infarction, or revascularization at 24 months. (Funded by Boston Scientific; FLAVOUR ClinicalTrials.gov number, NCT02673424.).
Keimyung Author(s)(Kor)
남창욱
Publisher
School of Medicine (의과대학)
Type
Article
ISSN
0028-4793
Source
https://www.nejm.org/doi/10.1056/NEJMoa2201546#article_references
DOI
10.1056/NEJMoa2201546
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/44570
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.